<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02566382</url>
  </required_header>
  <id_info>
    <org_study_id>RB 12.172 DESEP</org_study_id>
    <nct_id>NCT02566382</nct_id>
  </id_info>
  <brief_title>Preliminary Study of Feasibility of Arthrodesis Scapula-humeral Under Arthroscopy</brief_title>
  <acronym>DESEP</acronym>
  <official_title>Arthrodesis Gleno Humeral Under Arthroscopy in the Sequelae of Plexus Brachial Evaluation of the Technical Feasibility</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Brest</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Brest</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Arthrodesis shoulder blade/humerus under arthroscopy. Implementation of an external fixative
      spray at the proximal level in the thorn of the scapula and distal in the diaphysis humerus.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This trial is about the arthrodesis shoulder blade/humerus under arthroscopy. The main aim of
      this study is to be able to carry out a fusion scapula-humeral supplements in 6 months. It is
      required to provide the benefice risk over to reduce the hospitalisation 48 hours.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Insufisciency of recruitment
  </why_stopped>
  <start_date type="Actual">September 2015</start_date>
  <completion_date type="Actual">October 2017</completion_date>
  <primary_completion_date type="Actual">October 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Radiological fusion gleno humeral on side and front view after the 6th month of the arthroscopy interventional</measure>
    <time_frame>6 months</time_frame>
    <description>This outcome will be considered like a success if the investigators get a continuous bone matrix between the humeral head and glenoid on the scapula and bone frame continues between the humeral head and the acromion. This evaluation will be done by radiographies.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood loss</measure>
    <time_frame>3 days</time_frame>
    <description>The blood loss during and after the surgery will be calculated and will be considered like a success if the total blood loss are less than 600ml.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">1</enrollment>
  <condition>Arthroscopy Arthrodesis Gleno-humeral</condition>
  <arm_group>
    <arm_group_label>shoulder arthroscopy arthrodesis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The shoulder surgery will be realized under arthroscopy only.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>arthroscopy arthrodesis of the shoulder</intervention_name>
    <description>The shoulder surgery will be realized under arthroscopy only</description>
    <arm_group_label>shoulder arthroscopy arthrodesis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient having a deficit scapula-humeral mobility

          -  Impossibility of being operated for a preserving nervous surgery

          -  Patient affiliation with a social security

          -  Patient who signed inform consent

        Exclusion Criteria:

          -  Patient with No mobility in all the articulations of the shoulder

          -  Callus malunion of the higher end of the humerus or the glen of the scapula

          -  Unable to sign an inform consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Brest university hospital</name>
      <address>
        <city>Brest</city>
        <state>Bretagne</state>
        <zip>29200</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 29, 2015</study_first_submitted>
  <study_first_submitted_qc>October 1, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 2, 2015</study_first_posted>
  <last_update_submitted>October 18, 2017</last_update_submitted>
  <last_update_submitted_qc>October 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

